EVW Partner Stephen Nagler To Announce The Closing Of MedPro’s First Investment

  • EVW Partner Stephen Nagler, Executive Director of MedPro Investors, LLC will announce the closing of MedPro’s first investment. MedPro Investors LLC, an organization of healthcare professionals in nine countries, will close on its investment in Immunomic Therapeutics Inc. Immunomic is based on a unique technology from Johns Hopkins University for the enhanced efficacy and delivery of vaccines. Their first clinical trial in Red Cedar allergy demonstrated 100% efficacy in remediating the allergy.